Rituximab

9 registered clinical trials studyying Rituximab — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Pati NCT07257055	M.D. Anderson Cancer Center	Phase 2
Recruiting	Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial NCT05734794	The Children's Hospital of Zhejiang University School of Medicine	Phase 3
Unknown	Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases NCT05324917	The Affiliated Hospital of Qingdao University	—
Unknown	Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab. NCT04877496	Insel Gruppe AG, University Hospital Bern	—
Unknown	Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis NCT05332587	First Affiliated Hospital, Sun Yat-Sen University	Phase 3
Unknown	Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lym NCT04425824	Chinese Academy of Medical Sciences	Phase 2
Recruiting	Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children NCT06530004	The First Affiliated Hospital of Xiamen University	—
Unknown	Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma ( NCT03373019	Fudan University	Phase 2
Unknown	Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL NCT03958916	Sun Yat-sen University	—